{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:38:56Z","timestamp":1784615936627,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173036"],"award-info":[{"award-number":["82173036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472902"],"award-info":[{"award-number":["82472902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173088"],"award-info":[{"award-number":["82173088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52173150"],"award-info":[{"award-number":["52173150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204287"],"award-info":[{"award-number":["82204287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012497"],"award-info":[{"award-number":["2022A1515012497"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012383"],"award-info":[{"award-number":["2022A1515012383"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202206010117"],"award-info":[{"award-number":["202206010117"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.mtbio.2025.102655","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:58:35Z","timestamp":1765180715000},"page":"102655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Daidzein-engineered high-accumulation self-therapeutic nanoplatform drives androgen receptor degradation via ubiquitination-proteasome system to overcome enzalutamide resistance in castration-resistant prostate cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Zhaoxiang","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-3435","authenticated-orcid":false,"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2025.102655_bib1","article-title":"Update on prostate cancer epidemiology and risk Factors-A systematic review","author":"Bergengren","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mtbio.2025.102655_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mtbio.2025.102655_bib3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/01.ju.0000134888.22332.bb","article-title":"Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results","volume":"172","author":"Roehl","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.mtbio.2025.102655_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrurol.2012.237","article-title":"Adaptation or selection--mechanisms of castration-resistant prostate cancer","volume":"10","author":"Zong","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.mtbio.2025.102655_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.mtbio.2025.102655_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","article-title":"Genomic hallmarks and structural variation in metastatic prostate cancer","volume":"174","author":"Quigley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2025.102655_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ijbiomac.2022.07.058","article-title":"Structural and molecular insights into the mechanism of resistance to enzalutamide by the clinical mutants in androgen receptor (AR) in castration-resistant prostate cancer (CRPC) patients","volume":"218","author":"Khan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2025.102655_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","article-title":"Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2025.102655_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eururo.2017.01.011","article-title":"Comprehensive profiling of the androgen receptor in liquid biopsies from castration-resistant prostate cancer reveals novel Intra-AR structural variation and splice variant expression patterns","volume":"72","author":"De Laere","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mtbio.2025.102655_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/cpt.2679","article-title":"Post-marketing requirements for cancer drugs approved by the European medicines agency, 2004-2014","volume":"112","author":"Cherla","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.mtbio.2025.102655_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mattod.2024.11.006","article-title":"Receptor agonist\/antagonist-incorporated anticancer nanodrugs: design, materials, and strategies","volume":"82","author":"Hao","year":"2025","journal-title":"Mater. Today"},{"key":"10.1016\/j.mtbio.2025.102655_bib12","doi-asserted-by":"crossref","first-page":"16128","DOI":"10.1021\/acs.jmedchem.2c01487","article-title":"A comprehensive overview of small-molecule androgen receptor degraders: recent progress and future perspectives","volume":"65","author":"Ha","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mtbio.2025.102655_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2025.102655_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41587-021-01173-2","article-title":"The PROTAC gold rush","volume":"40","author":"Garber","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2025.102655_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115037","article-title":"PROTACS: a technology with a gold rush-like atmosphere","volume":"247","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mtbio.2025.102655_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ddc3010011","article-title":"Plant-derived natural products: a source for drug discovery and development","author":"Chaachouay","year":"2024","journal-title":"Drugs and Drug Candidates"},{"key":"10.1016\/j.mtbio.2025.102655_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081636","article-title":"The pros and cons of estrogens in prostate cancer: an update with a focus on phytoestrogens","volume":"12","author":"Figueira","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.mtbio.2025.102655_bib18","first-page":"533","article-title":"Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells","volume":"26","author":"Szliszka","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mtbio.2025.102655_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/1120009X.2021.1924935","article-title":"Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERbeta modulation, in vitro and in vivo studies","volume":"33","author":"Ranjithkumar","year":"2021","journal-title":"J. Chemother."},{"key":"10.1016\/j.mtbio.2025.102655_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1258\/ebm.2009.009128","article-title":"Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells","volume":"235","author":"Hsu","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.mtbio.2025.102655_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jn\/136.1.75","article-title":"Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells","volume":"136","author":"Handayani","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.mtbio.2025.102655_bib22","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/ptr.7852","article-title":"Pharmacokinetics, pharmacodynamics, toxicity, and formulations of daidzein: an important isoflavone","volume":"37","author":"Laddha","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.mtbio.2025.102655_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.mattod.2022.11.007","article-title":"Self-therapeutic nanomaterials: applications in biology and medicine","volume":"62","author":"Seaberg","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.mtbio.2025.102655_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mattod.2024.01.011","article-title":"Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis","volume":"73","author":"Tang","year":"2024","journal-title":"Mater. Today"},{"key":"10.1016\/j.mtbio.2025.102655_bib25","article-title":"Polyprodrug nanomedicines: an emerging paradigm for cancer therapy","volume":"34","author":"Yang","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.mtbio.2025.102655_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202100805","article-title":"Rebirth of aspirin synthesis by\u2010product: prickly poly(salicylic acid) nanoparticles as self\u2010anticancer drug carrier","volume":"31","author":"You","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2025.102655_bib27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Martinez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2025.102655_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.111956","article-title":"Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy","volume":"123","author":"Zhang","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.mtbio.2025.102655_bib29","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1007\/s12272-015-0592-9","article-title":"Pharmacokinetics of enzalutamide, an anti-prostate cancer drug, in rats","volume":"38","author":"Kim","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.mtbio.2025.102655_bib30","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1021\/acs.jmedchem.3c01668","article-title":"Design and synthesis of dual-target inhibitors targeting androgen receptors and glucocorticoid receptors to overcome antiandrogen resistance in castration-resistant prostate cancer","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mtbio.2025.102655_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.417","article-title":"Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-\u03b21\/STAT3 axis-regulated EMT","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mtbio.2025.102655_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41392-025-02444-z","article-title":"In vivo self-assembled nano-PROTAC for the dual degradation of AR and HSP90 to overcome castration-resistant prostate cancer resistance","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.mtbio.2025.102655_bib33","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.molcel.2022.02.027","article-title":"Protein degradation on the global scale","volume":"82","author":"Rusilowicz-Jones","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.mtbio.2025.102655_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120910","article-title":"Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation","volume":"275","author":"Luan","year":"2021","journal-title":"Biomaterials"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259000642501227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259000642501227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:20:47Z","timestamp":1773897647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259000642501227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S259000642501227X"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102655","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daidzein-engineered high-accumulation self-therapeutic nanoplatform drives androgen receptor degradation via ubiquitination-proteasome system to overcome enzalutamide resistance in castration-resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102655"}}